Exact Mass: 575.2067681999999
Exact Mass Matches: 575.2067681999999
Found 55 metabolites which its exact mass value is equals to given mass value 575.2067681999999
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Zafirlukast
C31H33N3O6S (575.2089958000001)
Zafirlukast is an oral leukotriene receptor antagonist (LTRA) for the maintenance treatment of asthma, often used in conjunction with an inhaled steroid and/or long-acting bronchodilator. It is available as a tablet and is usually dosed twice daily. Another leukotriene receptor antagonist is montelukast (Singulair), which is usually taken just once daily. Zafirlukast blocks the action of the cysteinyl leukotrienes on the CysLT1 receptors, thus reducing constriction of the airways, build-up of mucus in the lungs and inflammation of the breathing passages. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DC - Leukotriene receptor antagonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D020024 - Leukotriene Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent
O-alpha-D-glucopyranosyl-(1<*>4)-O-2-acetamido-2-deoxy-alpha-D-glucopyranosyl-(1<*>2)-D-glycero-L-manno-heptose|O-alpha-D-glucopyranosyl-(1[*]4)-O-2-acetamido-2-deoxy-alpha-D-glucopyranosyl-(1[*]2)-D-glycero-L-manno-heptose
zafirlukast
C31H33N3O6S (575.2089958000001)
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DC - Leukotriene receptor antagonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D020024 - Leukotriene Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent
Cys His Met Trp
Cys His Trp Met
Cys Met His Trp
Cys Met Trp His
Cys Gln Tyr Tyr
C26H33N5O8S (575.2049738000001)
Cys Trp His Met
Cys Trp Met His
Cys Tyr Gln Tyr
C26H33N5O8S (575.2049738000001)
Cys Tyr Tyr Gln
C26H33N5O8S (575.2049738000001)
His Cys Met Trp
His Cys Trp Met
His Met Cys Trp
His Met Trp Cys
His Trp Cys Met
His Trp Met Cys
Met Cys His Trp
Met Cys Trp His
Met His Cys Trp
Met His Trp Cys
Met Trp Cys His
Met Trp His Cys
Gln Cys Tyr Tyr
C26H33N5O8S (575.2049738000001)
Gln Tyr Cys Tyr
C26H33N5O8S (575.2049738000001)
Gln Tyr Tyr Cys
C26H33N5O8S (575.2049738000001)
Trp Cys His Met
Trp Cys Met His
Trp His Cys Met
Trp His Met Cys
Trp Met Cys His
Trp Met His Cys
Tyr Cys Gln Tyr
C26H33N5O8S (575.2049738000001)
Tyr Cys Tyr Gln
C26H33N5O8S (575.2049738000001)
Tyr Gln Cys Tyr
C26H33N5O8S (575.2049738000001)
Tyr Gln Tyr Cys
C26H33N5O8S (575.2049738000001)
Tyr Tyr Cys Gln
C26H33N5O8S (575.2049738000001)
Tyr Tyr Gln Cys
C26H33N5O8S (575.2049738000001)
N-[(2S,4aS,12aS)-2-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-fluorobenzamide
C31H30FN3O7 (575.2067681999999)
3,3,3-trifluoro-N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-8-(1-methylimidazol-4-yl)sulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
3,3,3-trifluoro-N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-8-[(1-methyl-4-imidazolyl)sulfonyl]-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
3,3,3-trifluoro-N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-8-(1-methylimidazol-4-yl)sulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-4-[3-(4-methoxyphenyl)phenyl]-N-(2,2,2-trifluoroethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
C29H32F3N3O4S (575.2065508000001)
N-[(2R,4aR,12aR)-2-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-fluorobenzamide
C31H30FN3O7 (575.2067681999999)
(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-4-[3-(4-methoxyphenyl)phenyl]-N-(2,2,2-trifluoroethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
C29H32F3N3O4S (575.2065508000001)
N-[(2R,4aR,12aS)-2-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-fluorobenzamide
C31H30FN3O7 (575.2067681999999)
N-[(2R,4aS,12aS)-2-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-fluorobenzamide
C31H30FN3O7 (575.2067681999999)
(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-4-[3-(3-methoxyphenyl)phenyl]-N-(2,2,2-trifluoroethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
C29H32F3N3O4S (575.2065508000001)
(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-4-[3-(3-methoxyphenyl)phenyl]-N-(2,2,2-trifluoroethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
C29H32F3N3O4S (575.2065508000001)
N-[(2R,4aS,12aR)-2-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-fluorobenzamide
C31H30FN3O7 (575.2067681999999)
N-[(2S,4aS,12aR)-2-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-fluorobenzamide
C31H30FN3O7 (575.2067681999999)
N-[(2S,4aR,12aR)-2-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-fluorobenzamide
C31H30FN3O7 (575.2067681999999)
N-[(2S,4aR,12aS)-2-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-fluorobenzamide
C31H30FN3O7 (575.2067681999999)